Clinical Trial Update: A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach [Phase 4]

View source ↗

Summary

Phase 4 study from Johannes Gutenberg University Mainz evaluating sequential substrate ablation for persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Atrial Fibrillation

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Persistent Atrial Fibrillation | Phase 4 | Status: COMPLETED